Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children
Robert S. B. Clark(Children's Hospital of Pittsburgh), Michael J. Bell(Children's National), Christopher M. Horvat(University of Pittsburgh), Alicia K. Au(Children's Hospital of Pittsburgh), Samuel M. Poloyac(University of Pittsburgh), Bedda L. Rosario(University of Pittsburgh), Hülya Bayır(Columbia University Irving Medical Center), Stephen R. Wisniewski(University of Iowa), Philip E. Empey(University of Pittsburgh), Patrick M. Kochanek(University of Pittsburgh), Thomas D. Nolin(Yamaha (Japan))
Cited by 56
Related Papers
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
|Neurosurgery|2016|4.3k
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
|Autophagy|2008|2k
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
|Resuscitation|2008|1.5k
Post–Cardiac Arrest Syndrome
|Circulation|2008|1.4k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k